{"disease":{"id":"myelogenous-leukemia-chronic-aggressive-phase","name":"myelogenous leukemia chronic aggressive phase"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00907517","title":"Study of SCH 900776 (MK-8776) With and Without Cytarabine in Participants With Acute Leukemias (P05247)","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":24,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}